Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,791
Closed -$201K 495
2024
Q4
$201K Buy
2,791
+63
+2% +$4.92K 0.01% 429
2024
Q3
$222K Sell
2,728
-19
-0.7% -$1.52K 0.02% 401
2024
Q2
$204K Sell
2,747
-86
-3% -$6.45K 0.01% 418
2024
Q1
$221K Buy
+2,833
New +$211K 0.02% 426
2023
Q4
Sell
-2,988
Closed -$207K 487
2023
Q3
$207K Sell
2,988
-336
-10% -$25.4K 0.02% 436
2023
Q2
$269K Buy
3,324
+56
+2% +$4.58K 0.02% 420
2023
Q1
$264K Sell
3,268
-137
-4% -$11K 0.02% 418
2022
Q4
$255K Buy
3,405
+11
+0.3% +$783 0.02% 422
2022
Q3
$219K Buy
+3,394
New +$235K 0.02% 426
2022
Q2
Sell
-2,912
Closed -$223K 496
2022
Q1
$223K Hold
2,912
0.02% 447
2021
Q4
$223K Buy
+2,912
New +$214K 0.02% 447

Other funds holding HOLX

Clarius Group LLC's HOLX Position: Q1 2025 in Review

Clarius Group LLC sold out of Hologic (HOLX) in Q1 2025, closing a stake of 2,791 shares — an estimated $201K sold.

Clarius Group LLC first reported a position in HOLX in Q4 2021 and held it in 11 quarters. The position peaked at $269K in Q2 2023. 706 funds tracked by Wall St. Rank hold HOLX as of Q1 2025.

  • Clarius Group LLC reported no remaining Hologic position as of Q1 2025 after selling out during the quarter.
  • Clarius Group LLC sold 2,791 Hologic shares in Q1 2025, an estimated $201K.
  • Clarius Group LLC first reported a position in Hologic in Q4 2021 and held it in 11 quarters.
  • Clarius Group LLC's Hologic position peaked at $269K in Q2 2023.
  • 706 funds tracked by Wall St. Rank held Hologic as of Q1 2025.

Based on Clarius Group LLC's 13F filing for Q1 2025, filed 18 Apr 2025.